Amina Ali

发表

Assessment of circulating tumor cells (CTCs) in prostate cancer patients with low‐volume tumors

J. Moul, S. Srivastava, I. Sesterhenn, 2010, Pathology international.

Multi-omic serum biomarkers for prognosis of disease progression in prostate cancer

S. Srivastava, I. Sesterhenn, V. Tolstikov, 2020, Journal of Translational Medicine.

Prostate cancer marker panel with single cell sensitivity in urine

S. Srivastava, I. Sesterhenn, G. Petrovics, 2015, The Prostate.

Diagnostic potential of prostate-specific antigen expressing epithelial cells in blood of prostate cancer patients.

J. Moul, S. Srivastava, R. Connelly, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Diagnostic potential of serum proteomic patterns in prostate cancer.

Bao-Ling Adam, Amina Ali, J. Moul, 2003, The Journal of urology.

Increased frequency of germline BRCA2 mutations associates with prostate cancer metastasis in a racially diverse patient population

S. Ambs, S. Srivastava, I. Sesterhenn, 2018, Prostate Cancer and Prostatic Diseases.

A Urine Exosome Gene Expression Panel Distinguishes Between Indolent and Aggressive Prostate Cancers at Biopsy.

S. Srivastava, I. Sesterhenn, S. Srivastava, 2020, The Journal of urology.

Methylation of the PMEPA1 gene, a negative regulator of the androgen receptor in prostate cancer

S. Srivastava, I. Sesterhenn, Hua Li, 2014, Epigenetics.

Autoantibodies against oncogenic ERG protein in prostate cancer: potential use in diagnosis and prognosis in a panel with C-MYC, AMACR and HERV-K Gag

S. Srivastava, I. Sesterhenn, S. Srivastava, 2016, Genes & cancer.

Increased frequency of germline BRCA2 mutations associates with prostate cancer metastasis in a racially diverse patient population

S. Ambs, S. Srivastava, I. Sesterhenn, 2018, Prostate Cancer and Prostatic Diseases.

PCA3 score before radical prostatectomy predicts extracapsular extension and tumor volume.

S. Srivastava, I. Sesterhenn, Yongmei Chen, 2008, The Journal of urology.

A Biopsy-based 17-gene Genomic Prostate Score Predicts Recurrence After Radical Prostatectomy and Adverse Surgical Pathology in a Racially Diverse Population of Men with Clinically Low- and Intermediate-risk Prostate Cancer.

Nan Zhang, Amina Ali, P. Febbo, 2015, European urology.

Prostate Cancer A Biopsy-based 17-gene Genomic Prostate Score Predicts Recurrence After Radical Prostatectomy and Adverse Surgical Pathology in a Racially Diverse Population of Men with Clinically Low-and Intermediate-risk Prostate Cancer

P. Febbo, S. Srivastava, I. Sesterhenn, 2015 .

Germline mutation landscape of DNA damage repair genes in African Americans with prostate cancer highlights potentially targetable RAD genes

S. Srivastava, I. Sesterhenn, H. Pollard, 2022, Nature Communications.

Prostate Cancer Risk Allele Specific for African Descent Associates with Pathologic Stage at Prostatectomy

S. Srivastava, M. Freedman, Yongmei Chen, 2010, Cancer Epidemiology, Biomarkers & Prevention.

Multi-omic serum biomarkers for prognosis of disease progression in prostate cancer

S. Srivastava, I. Sesterhenn, V. Tolstikov, 2020, Journal of Translational Medicine.

Association of germline genetic variants with TMPRSS2-ERG fusion status in prostate cancer

Qiyuan Li, S. Srivastava, M. Freedman, 2020, Oncotarget.

Evaluation of the ETS-Related Gene mRNA in Urine for the Detection of Prostate Cancer

S. Srivastava, I. Sesterhenn, S. Miick, 2010, Clinical Cancer Research.

Clinical utility of a serum biomarker panel in distinguishing prostate cancer from benign prostate hyperplasia

Jeonifer M. Garren, S. Srivastava, E. Diamandis, 2021, Scientific Reports.

Evaluation of the ETS-Related Gene mRNA in Urine for the Detection of Prostate Cancer

S. Srivastava, I. Sesterhenn, S. Miick, 2010, Clinical Cancer Research.